Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01)
Description
This Funding Opportunity Announcement (FOA) invites applications for grant funding to conduct Large Research Projects (R01) focused on Combating Antibiotic-Resistant Bacteria (CARB) .
CFDA Number
93.226
Funding Instrument
Grant
Funding Level
Federal
Jurisdiction
US
Cost Sharing
No
Open Date
October 21, 2021
Close Date
October 30, 2026
Posted Date
October 21, 2021
Eligible Applicant Types
County governmentsNative American tribal governments (Federally recognized)Special district governmentsNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationNative American tribal organizations (other than Federally recognized tribal governments)Others (see text field entitled "Additional Information on Eligibility" for clarification)Public and State controlled institutions of higher educationState governmentsNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationCity or township governmentsPublic housing authorities/Indian housing authoritiesIndependent school districtsPrivate institutions of higher education
Tags
HHS-AHRQCFDA:93.226GrantHealth
Related Health & Human Services Grants
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
National Institutes of Health
0d left
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
National Institutes of Health
0d left
HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institutes of Health
0d left
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
National Institutes of Health
0d left